Bonavina L, Segalin A, Rosati R, Pavanello M, Peracchia A
Department of General and Oncologic Surgery, University of Milan, Italy.
J Am Coll Surg. 1995 Sep;181(3):257-62.
Surgical enucleation is the treatment of choice in selected patients with esophageal leiomyoma. The video-thoracoscopic approach can potentially cause less patient discomfort postoperatively and reduce the hospital stay and recovery period.
A retrospective evaluation of 66 patients who underwent surgical therapy for esophageal leiomyoma over a 27-year period was done. The main symptoms were dysphagia in 35 (53 percent) patients, heartburn or regurgitation, or both, in 11 (17 percent) patients, and retrosternal pain in ten (15 percent) patients. Associated esophageal disorders were found in 19 patients (some patients had more than one disorder): hiatal hernia in 15 (23 percent), epiphrenic diverticulum in four (6 percent), and achalasia in three (5 percent). The operation consisted of leiomyoma enucleation in 63 patients, and esophageal resection in three. In six patients, the enucleation was successfully performed by video-thoracoscopy combined with intraoperative esophagoscopy. The muscle layer of the esophagus was approximated in the majority of the patients after tumor enucleation.
There was no operative mortality. The incidence of intraoperative esophageal perforation was greater in patients who had previously undergone endoscopic biopsy (p < 0.01). In one patient, a pseudodiverticulum developed after thoracoscopic enucleation, requiring reoperation with approximation of the muscle layer for relief of dysphagia. The length of hospital stay was shorter in patients undergoing the video-assisted operation (p < 0.05). The median follow-up period was 53 months (range, 12 to 248 months). No recurrence of leiomyoma was observed. Overall, seven (11 percent) patients complained of heartburn or epigastric pain, or both, which was responsive to antisecretory drugs, but only three had such symptoms induced by the operation. In two patients the symptoms appeared after combined treatment of an epiphrenic diverticulum, and in one patient after simple leiomyoma enucleation.
Enucleation of esophageal leiomyoma is a safe and effective operation. The video-thoracoscopic approach combined with intraoperative esophagoscopy allows performance of this procedure with the added advantage of shortening hospital stay. The muscle layer of the esophagus should be approximated to avoid decreasing the propulsive activity of the esophageal body. This may improve the long-term outcome of the operation by preserving the acid-clearing mechanism of the esophagus and reducing the incidence of postoperative reflux esophagitis.
手术摘除术是部分食管平滑肌瘤患者的首选治疗方法。电视胸腔镜手术可能会减少患者术后不适,缩短住院时间和恢复周期。
对66例在27年期间接受食管平滑肌瘤手术治疗的患者进行回顾性评估。主要症状为吞咽困难35例(53%),烧心或反流或两者皆有11例(17%),胸骨后疼痛10例(15%)。19例患者存在相关食管疾病(部分患者有不止一种疾病):食管裂孔疝15例(23%),膈上憩室4例(6%),贲门失弛缓症3例(5%)。63例患者行平滑肌瘤摘除术,3例患者行食管切除术。6例患者通过电视胸腔镜联合术中食管镜成功完成摘除术。大多数患者在肿瘤摘除术后对食管肌层进行了缝合。
无手术死亡病例。既往接受过内镜活检的患者术中食管穿孔发生率更高(p<0.01)。1例患者在胸腔镜摘除术后出现假性憩室,需要再次手术缝合肌层以缓解吞咽困难。接受电视辅助手术的患者住院时间更短(p<0.05)。中位随访期为53个月(范围12至248个月)。未观察到平滑肌瘤复发。总体而言,7例(11%)患者主诉烧心或上腹部疼痛或两者皆有,对抗分泌药物有反应,但只有3例症状由手术引起。2例患者在膈上憩室联合治疗后出现症状,1例患者在单纯平滑肌瘤摘除术后出现症状。
食管平滑肌瘤摘除术是一种安全有效的手术。电视胸腔镜手术联合术中食管镜可进行该手术,且具有缩短住院时间的额外优势。应缝合食管肌层以避免降低食管体的推进活性。这可能通过保留食管的酸清除机制和降低术后反流性食管炎的发生率来改善手术的长期效果。